about
A systematic review of observational studies evaluating costs of adverse drug reactionsAssessment of ePrescription quality: an observational study at three mail-order pharmacies.Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization.Epidemiology of adverse drug reactions in Europe: a review of recent observational studiesAdverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational studyAwareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey.Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients.Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADREvaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study.How are the costs of drug-related morbidity measured?: a systematic literature review.Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.Cost of adverse drug reactions in a South Indian tertiary care teaching hospital.Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.A prospective analysis of the preventability of adverse drug reactions reported in Sweden.Drug-induced blood consumption: the impact of adverse drug reactions on demand for blood components in German departments of internal medicine.
P2860
Q28079380-50EB3119-C741-4355-A06A-C3937BDDEAF6Q33403064-A359E4F2-86A9-4EB0-B45A-5A92E6272E8EQ33901424-467D30FD-27C0-49AE-B99E-DC0373364B91Q34537662-ED3032BA-1D70-4372-843A-0EEC900CF091Q34657198-C01A144A-1CA4-4776-AEAA-4520AAB6612BQ35546999-7970BB4F-E336-49D7-92A5-2A9622EFB3D5Q36535969-5B4E308F-F14D-49E0-BDF3-17CDE79DA34DQ36867437-55D13739-956F-41BF-92B6-4DFF886CAF24Q36939152-D034ABF4-511A-44B9-BC12-0270F9CC165BQ36951924-1D27A285-6C43-4B07-AA91-5DAA59031F45Q37099049-3666220B-E8C4-4082-9A40-429C17F5D0CAQ37173976-A8679AF6-D5C5-44B7-A72D-77A516C63C72Q37975521-702E2B7A-689D-451E-81D6-2EC9082414E9Q38129733-3E5F566D-1D6D-41B2-A548-7D9A24D9D2C8Q44970881-6E61A8F6-C6A5-48A7-89BB-975592A0E1F0Q45113251-0003A03D-AAE4-4AD8-B2C0-BF4F06F9F86AQ45158316-E4D626D9-7E29-4793-B194-AD60E4692F50Q45284924-CD8F25AA-54B9-415D-8016-798083B43309Q47927135-58578C52-9FD9-4FAB-A726-5A14DCA804F1
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacoeconomics of adverse drug reactions.
@ast
Pharmacoeconomics of adverse drug reactions.
@en
type
label
Pharmacoeconomics of adverse drug reactions.
@ast
Pharmacoeconomics of adverse drug reactions.
@en
prefLabel
Pharmacoeconomics of adverse drug reactions.
@ast
Pharmacoeconomics of adverse drug reactions.
@en
P2860
P1476
Pharmacoeconomics of adverse drug reactions.
@en
P2093
Bengt Jönsson
Jonas Lundkvist
P2860
P304
P356
10.1111/J.1472-8206.2004.00239.X
P577
2004-06-01T00:00:00Z